GSK (GSK) News Today $41.58 +0.29 (+0.69%) Closing price 06/11/2025 03:59 PM EasternExtended Trading$42.44 +0.85 (+2.06%) As of 08:39 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GSK Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Cohen Klingenstein LLC Has $3.08 Million Stake in GSK plc (NYSE:GSK)Cohen Klingenstein LLC trimmed its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 19.1% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 79,398 shares of the pharmaceutical company's stock after selling 18,800 shares duringJune 11 at 8:53 AM | marketbeat.comGSK plc (NYSE:GSK) Shares Bought by Bard Financial Services Inc.Bard Financial Services Inc. raised its position in GSK plc (NYSE:GSK - Free Report) by 54.6% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 122,245 shares of the pharmaceutical company's stock after buying an additional 43,150 shaJune 11 at 7:42 AM | marketbeat.comMADDEN SECURITIES Corp Has $4.14 Million Holdings in GSK plc (NYSE:GSK)MADDEN SECURITIES Corp increased its stake in shares of GSK plc (NYSE:GSK - Free Report) by 22.2% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 106,830 shares of the pharmaceutical company's stock after acquiring an additional 19,400 shareJune 10 at 6:58 AM | marketbeat.comPark Avenue Securities LLC Buys 25,111 Shares of GSK plc (NYSE:GSK)Park Avenue Securities LLC grew its position in shares of GSK plc (NYSE:GSK - Free Report) by 47.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 77,630 shares of the pharmaceutical company's stock after buying an addJune 10 at 4:38 AM | marketbeat.com20,775 Shares in GSK plc (NYSE:GSK) Bought by Merit Financial Group LLCMerit Financial Group LLC bought a new position in GSK plc (NYSE:GSK - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 20,775 shares of the pharmaceutical company's stock, valued at approximately $805,00June 9 at 4:09 AM | marketbeat.comBrokerages Set GSK plc (NYSE:GSK) Price Target at $37.38June 9 at 2:23 AM | americanbankingnews.comGSK Expands Share Buyback Program with Recent PurchaseJune 9 at 2:13 AM | tipranks.comClean Yield Group Trims Stock Holdings in GSK plc (NYSE:GSK)Clean Yield Group reduced its position in GSK plc (NYSE:GSK - Free Report) by 10.5% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 179,114 shares of the pharmaceutical company's stock after selling 20,949 shares during the quarter. GSKJune 8, 2025 | marketbeat.comGSK plc (NYSE:GSK) Shares Purchased by Stablepoint Partners LLCStablepoint Partners LLC raised its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 21.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 120,796 shares of the pharmaceutJune 6, 2025 | marketbeat.comGSK plc (NYSE:GSK) Receives Consensus Rating of "Hold" from BrokeragesGSK plc (NYSE:GSK - Get Free Report) has earned an average recommendation of "Hold" from the eleven ratings firms that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, eight have given a hold rating and two have issued a strong buyJune 6, 2025 | marketbeat.comGSK cut to Hold by Berenberg as investors await proof from upcoming drug launchesJune 4, 2025 | finance.yahoo.comNuveen Asset Management LLC Sells 7,310 Shares of GSK plc (NYSE:GSK)Nuveen Asset Management LLC decreased its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 14.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 42,293 shares of the pharmaceutical company's stock after sellinJune 4, 2025 | marketbeat.comGSK (NYSE:GSK) Receives "Hold" Rating from Berenberg BankJune 4, 2025 | americanbankingnews.comGSK (NYSE:GSK) Shares Gap Down - Should You Sell?GSK (NYSE:GSK) Shares Gap Down - Time to Sell?June 3, 2025 | marketbeat.comDow Jones Industrial Average (DIA) Live June 3: OECD Cuts US GDP Forecast, DIA DivesJune 3, 2025 | 247wallst.comBerenberg Bank Reaffirms Hold Rating for GSK (NYSE:GSK)Berenberg Bank restated a "hold" rating on shares of GSK in a research note on Tuesday.June 3, 2025 | marketbeat.comWhipplewood Advisors LLC Acquires 58,785 Shares of GSK plc (NYSE:GSK)Whipplewood Advisors LLC grew its holdings in GSK plc (NYSE:GSK - Free Report) by 4,367.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 60,131 shares of the pharmaceutical company's stock after acquiring an additionJune 3, 2025 | marketbeat.comNBC Securities Inc. Increases Position in GSK plc (NYSE:GSK)NBC Securities Inc. lifted its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 108,287.5% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 34,684 shares of the pharmaceutical company's stock after acquiring an additiJune 3, 2025 | marketbeat.comGAMMA Investing LLC Has $66.74 Million Stock Position in GSK plc (NYSE:GSK)GAMMA Investing LLC increased its stake in shares of GSK plc (NYSE:GSK - Free Report) by 7,950.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 172,277 shares of the pharmaceutical compJune 3, 2025 | marketbeat.comWealth Enhancement Advisory Services LLC Buys 13,039 Shares of GSK plc (NYSE:GSK)Wealth Enhancement Advisory Services LLC raised its stake in GSK plc (NYSE:GSK - Free Report) by 8.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 174,688 shares of the pharmaceutical company's stock after buying an additJune 3, 2025 | marketbeat.comDouglas Lane & Associates LLC Trims Holdings in GSK plc (NYSE:GSK)Douglas Lane & Associates LLC cut its holdings in GSK plc (NYSE:GSK - Free Report) by 6.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,521,526 shares of the pharmaceutical company's stock after selling 106,978June 2, 2025 | marketbeat.comJTC Employer Solutions Trustee Ltd Has $591.57 Million Position in GSK plc (NYSE:GSK)JTC Employer Solutions Trustee Ltd reduced its stake in shares of GSK plc (NYSE:GSK - Free Report) by 24.7% in the first quarter, according to its most recent filing with the SEC. The fund owned 15,260,368 shares of the pharmaceutical company's stock after selling 5,018,196 shares during the periodJune 2, 2025 | marketbeat.comTheravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 MillionJune 2, 2025 | prnewswire.comUS FDA accepts new drug application for GSK's liver drug linerixibatJune 2, 2025 | lse.co.ukGSK plc (NYSE:GSK) Shares Sold by Deutsche Bank AGDeutsche Bank AG decreased its holdings in GSK plc (NYSE:GSK - Free Report) by 99.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 7,676 shares of the pharmaceutical company's stock after selling 742,739 sharesJune 2, 2025 | marketbeat.comVersant Capital Management Inc Has $245,000 Position in GSK plc (NYSE:GSK)Versant Capital Management Inc increased its stake in shares of GSK plc (NYSE:GSK - Free Report) by 7,077.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,316 shares of the pharmaceuticalJune 1, 2025 | marketbeat.comNorthCrest Asset Manangement LLC Reduces Stock Holdings in GSK plc (NYSE:GSK)NorthCrest Asset Manangement LLC cut its position in shares of GSK plc (NYSE:GSK - Free Report) by 98.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 7,392 shares of the pharmaceutical company's stock after selling 376,196 sJune 1, 2025 | marketbeat.comGSK (NYSE:GSK) Cut to Hold at Wall Street ZenWall Street Zen lowered GSK from a "buy" rating to a "hold" rating in a report on Friday.June 1, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Acquires Shares of 405,963 GSK plc (NYSE:GSK)Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of GSK plc (NYSE:GSK - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 405,963 shares of the pharMay 31, 2025 | marketbeat.comGSK plc (NYSE:GSK) Shares Purchased by First Hawaiian BankFirst Hawaiian Bank lifted its position in GSK plc (NYSE:GSK - Free Report) by 18.8% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 101,039 shares of the pharmaceutical company's stock after purchasing an adMay 30, 2025 | marketbeat.comWellington Management Group LLP Acquires 190,047 Shares of GSK plc (NYSE:GSK)Wellington Management Group LLP lifted its stake in GSK plc (NYSE:GSK - Free Report) by 10.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,094,105 shares of the pharmaceutical company's stock after purchasinMay 30, 2025 | marketbeat.comGSK-licensed antibiotic meets goal in late-stage studyMay 29, 2025 | finance.yahoo.comGSK and Spero halt UTI antibiotic trial early due to high efficacyMay 29, 2025 | finance.yahoo.comiTeos to shut down following $2bn GSK-partnered TIGIT asset failureMay 29, 2025 | finance.yahoo.comNorthstar Financial Companies Inc. Invests $228,000 in GSK plc (NYSE:GSK)Northstar Financial Companies Inc. acquired a new position in GSK plc (NYSE:GSK - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 6,735 shares of the pharmaceutical company's stock, valued at approximately $228,000.May 29, 2025 | marketbeat.com8,459 Shares in GSK plc (NYSE:GSK) Acquired by Aegis Wealth Management LLCAegis Wealth Management LLC bought a new stake in shares of GSK plc (NYSE:GSK - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 8,459 shares of the pharmaceutical company's stock, valued at approximately $286,000. A numbeMay 29, 2025 | marketbeat.comBridgePort Financial Solutions LLC Makes New $310,000 Investment in GSK plc (NYSE:GSK)BridgePort Financial Solutions LLC acquired a new position in shares of GSK plc (NYSE:GSK - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 8,318 shares of the pharmaceutical company's stock, valued at approximately $310,000. Several otheMay 29, 2025 | marketbeat.comWhy Is GSK Partner Spero Therapeutics Stock Skyrocketing On Wednesday?May 28, 2025 | benzinga.comGSK, Spero to stop urinary tract infection drug trial due to early successMay 28, 2025 | reuters.comBrucke Financial Inc. Makes New $465,000 Investment in GSK plc (NYSE:GSK)Brucke Financial Inc. purchased a new position in GSK plc (NYSE:GSK - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 13,184 shares of the pharmaceutical company's stock, valued at approMay 28, 2025 | marketbeat.comSpero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring CommitteeMay 28, 2025 | globenewswire.comYoffe Investment Management LLC Makes New $462,000 Investment in GSK plc (NYSE:GSK)Yoffe Investment Management LLC acquired a new stake in GSK plc (NYSE:GSK - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 13,657 shares of the pharmaceutical company's stock, valued at approximately $462,000.May 28, 2025 | marketbeat.comTotal Wealth Planning & Management Inc. Acquires Shares of 11,525 GSK plc (NYSE:GSK)Total Wealth Planning & Management Inc. bought a new stake in shares of GSK plc (NYSE:GSK - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 11,525 shares of the pharmaceutical company's stock, valued at approximatMay 28, 2025 | marketbeat.comGSK plc (NYSE:GSK) Shares Sold by Employees Retirement System of TexasEmployees Retirement System of Texas reduced its stake in GSK plc (NYSE:GSK - Free Report) by 43.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 95,136 shares of the pharmaceutical company'sMay 28, 2025 | marketbeat.comForum Financial Management LP Has $453,000 Stake in GSK plc (NYSE:GSK)Forum Financial Management LP boosted its holdings in GSK plc (NYSE:GSK - Free Report) by 167.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,397 shares of the pharmaceutical compMay 28, 2025 | marketbeat.comGSK Expands Share Buyback Program with Latest PurchaseMay 28, 2025 | tipranks.comWaverly Advisors LLC Buys 7,025 Shares of GSK plc (NYSE:GSK)Waverly Advisors LLC grew its stake in GSK plc (NYSE:GSK - Free Report) by 113.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,233 shares of the pharmaceutical company's stock after purchaMay 27, 2025 | marketbeat.comZacks Research Issues Optimistic Forecast for GSK EarningsGSK plc (NYSE:GSK - Free Report) - Equities researchers at Zacks Research raised their Q3 2025 earnings estimates for shares of GSK in a research report issued to clients and investors on Wednesday, May 21st. Zacks Research analyst E. Bagri now anticipates that the pharmaceutical company will earMay 27, 2025 | marketbeat.comMichels Family Financial LLC Acquires New Stake in GSK plc (NYSE:GSK)Michels Family Financial LLC bought a new position in shares of GSK plc (NYSE:GSK - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 11,150 shares of the pharmaceutical company's stock, valued at approximately $377May 26, 2025 | marketbeat.comDrucker Wealth 3.0 LLC Has $2.32 Million Position in GSK plc (NYSE:GSK)Drucker Wealth 3.0 LLC lowered its position in shares of GSK plc (NYSE:GSK - Free Report) by 17.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 68,665 shares of the pharmaceutical company's stock after selling 15,001 shares during the quMay 26, 2025 | marketbeat.com Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address GSK Media Mentions By Week GSK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼1.150.87▲Average Medical News Sentiment GSK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼1018▲GSK Articles Average Week Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Novartis News Today AstraZeneca News Today Sanofi News Today Takeda Pharmaceutical News Today argenx News Today Beigene News Today BioNTech News Today Teva Pharmaceutical Industries News Today Summit Therapeutics News Today Genmab A/S News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:GSK) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GSK With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GSK Stock Free GSK Stock Alerts